Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKaiser Permanente

About this trial

The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking.

The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months.

The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.

Eligibility criteria

Qualifiers

18 years of age and older

Current cigarette smoker who is ambivalent about smoking

Not actively using any treatment to quit smoking

Own and regularly use a smartphone

Disqualifiers

A lifetime history of dementia or psychosis

Visual impairments that prevent viewing phone content and they lack adaptive devices

Report medical contra-indications for over-the-counter NRT use

Due to the potential for bias introduced by fraudulent participants, other exclusions will be applied to deter fraudulent enrollment.

Trial design

Treatments tested in this trial

  • Control Intervention
  • Experimental Intervention

Treatment groups

800 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Kaiser Permanente

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Fred Hutchinson Cancer Center

Collaborator

University of California, Davis

Collaborator